Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pretransplant Numbers of CD16+ Monocytes as a Novel Biomarker to Predict Acute Rejection After Kidney Transplantation: A Pilot Study.
van den Bosch TPP, Hilbrands LB, Kraaijeveld R, Litjens NHR, Rezaee F, Nieboer D, Steyerberg EW, van Gestel JA, Roelen DL, Clahsen-van Groningen MC, Baan CC, Rowshani AT. van den Bosch TPP, et al. Among authors: van gestel ja. Am J Transplant. 2017 Oct;17(10):2659-2667. doi: 10.1111/ajt.14280. Epub 2017 Apr 22. Am J Transplant. 2017. PMID: 28332287 Free article.
Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer.
Peters FS, Peeters AMA, van den Bosch TPP, Mooyaart AL, van de Wetering J, Betjes MGH, Baan CC, Boer K. Peters FS, et al. Among authors: van de wetering j, van den bosch tpp. Clin Exp Immunol. 2019 Sep;197(3):341-351. doi: 10.1111/cei.13309. Epub 2019 May 30. Clin Exp Immunol. 2019. PMID: 31059128 Free PMC article. Clinical Trial.
The mast cell: A Janus in kidney transplants.
van der Elst G, Varol H, Hermans M, Baan CC, Duong-van Huyen JP, Hesselink DA, Kramann R, Rabant M, Reinders MEJ, von der Thüsen JH, van den Bosch TPP, Clahsen-van Groningen MC. van der Elst G, et al. Among authors: van den bosch tpp. Front Immunol. 2023 Feb 20;14:1122409. doi: 10.3389/fimmu.2023.1122409. eCollection 2023. Front Immunol. 2023. PMID: 36891297 Free PMC article. Review.
Corrigendum: The mast cell: A Janus in kidney transplants.
van der Elst G, Varol H, Hermans M, Baan CC, Duong-van Huyen JP, Hesselink DA, Kramann R, Rabant M, Reinders MEJ, von der Thüsen JH, van den Bosch TPP, Clahsen-van Groningen MC. van der Elst G, et al. Among authors: van den bosch tpp. Front Immunol. 2023 Mar 21;14:1183969. doi: 10.3389/fimmu.2023.1183969. eCollection 2023. Front Immunol. 2023. PMID: 37026016 Free PMC article.
Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids.
Leunissen DJG, Moonen L, von der Thüsen JH, den Bakker MA, Hillen LM, van Weert TJJ, Zur Hausen A, van den Bosch TPP, Lap LMV, Damhuis RA, Reynaert NL, van den Broek EC; PALGA group; Fernandez-Cuesta L, Foll M, Alcala N, Sexton-Oates A, Dingemans AC, Speel EM, Derks JL. Leunissen DJG, et al. Among authors: van den bosch tpp. J Thorac Oncol. 2024 Nov 22:S1556-0864(24)02481-X. doi: 10.1016/j.jtho.2024.11.018. Online ahead of print. J Thorac Oncol. 2024. PMID: 39581377 Free article.
A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for Glioblastoma.
Ntafoulis I, Koolen SLW, van Tellingen O, den Hollander CWJ, Sabel-Goedknegt H, Dijkhuizen S, Haeck J, Reuvers TGA, de Bruijn P, van den Bosch TPP, van Dis V, Gao Z, Dirven CMF, Leenstra S, Lamfers MLM. Ntafoulis I, et al. Among authors: van den bosch tpp. Pharmaceuticals (Basel). 2024 Dec 14;17(12):1687. doi: 10.3390/ph17121687. Pharmaceuticals (Basel). 2024. PMID: 39770529 Free PMC article.
84 results